The South Florida Business Journal recently highlighted TAVRA Biosciences and the growing investment in cell-based manufacturing infrastructure in South Florida.
The article explores how Florida’s evolving stem cell framework is creating demand for high-quality, consistently manufactured products. TAVRA founder Priya Chordia discussed the importance of building a reliable supply of products that physicians can evaluate with confidence.
At TAVRA, we are focused on bringing greater consistency, quality oversight, and scalability to the cell-based product market.
Link: Read the full article in the South Florida Business Journal